GlassScriptPhysician profile
Catherine L Mathes
NPI 1427092808
$6,723.11
in general payments reported to CMS, 2019-2025
47 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,099 · 2020: $698 · 2021: $1,219 · 2022: $1,106 · 2023: $934 · 2024: $421 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,600.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,046.18 | 2019-2024 | |
| Novo Nordisk INC | $647.48 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $536.41 | 2019-2023 | Belsomra, Verquvo |
| Lilly USA, LLC | $511.25 | 2020-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $424.77 | 2019-2024 | Shingrix, Arexvy, Bexsero |
| Abbvie INC. | $419.67 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $374.11 | 2019-2024 | Airsupra, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $308.60 | 2019-2023 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $252.16 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $228.96 | 2019-2024 | Jardiance |
| Amgen INC. | $211.06 | 2019-2024 | Prolia, Evenity |
| Allergan, INC. | $162.84 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $146.73 | 2019-2022 | |
| Amarin Pharma, INC. | $138.77 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $135.14 | 2019-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Mathes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.